search Created with Sketch.

In This Issue

Editors' Page

You Got Skills?

Iqbal Ike K. Ahmed, MD, FRCSC

The Literature

Light on the Horizon

Evidence from randomized controlled trials supports the use of two less invasive glaucoma treatment options, selective laser trabeculoplasty and a microstent.

Chelvin Sng, MBBChir, MA, MMed, FRCS(Ed), and Keith Barton, MD, FRCP, FRCS

Research Update

Highlights of the 2019 AGS Annual Meeting

Catch up on research comparing glaucoma surgical procedures, examining real-world diagnosis and treatment, and exploring the nature of the disease itself.

Sarwat Salim, MD, FACS, and Albert S. Khouri, MD

Case Files

Glaucoma or Something Else?

Physicians explore whether another form of optic neuropathy caused this patient's visual
field loss.

Thomas Patrianakos, MD; Shakeel Shareef, MD; and Arthur J. Sit, MD

Technical Talk

The Fundamentals of GATT

Tips and tricks for performing this cost-effective glaucoma surgery.

Zeynep Aktas, MD, FEBO

Residents & Fellows

Lessons From Abroad

Discovering the value of international outreach during glaucoma fellowship.

Matthew Miller, MD

Global Perspectives

Surgical Approaches to Glaucoma in Africa

Enormous challenges exist, but pragmatic advances are being made.

Dan Kiage, MD, MB ChB, MMed, FEACO

Cover Focus

The Unknowns of the Outflow Pathway

A better understanding of what governs the homeostasis of outflow is vital to understanding the early pathology of glaucoma.

Ronald L. Fellman, MD, and Davinder S. Grover, MD, MPH

The Suprachoroidal Space: The Next Frontier

A look at emerging technologies targeting the suprachoroidal space.

R. Allan Sharpe, MD, and Peter T. Chang, MD

Preventing Postoperative Fibrosis

A look at different approaches to managing postoperative fibrosis after glaucoma surgery.

Ian Pitha, MD, PhD

PGA-Targeted Outflow Pathways

A closer look at the mechanism of action for a familiar medication class.

Jacob W. Brubaker, MD

The Trabecular Meshwork and ROCK Inhibitors

Reviewing the mechanisms behind one of the newest classes of glaucoma drugs.

Mehak Aziz, MD, and Rachel W. Kuchtey, MD, PhD

Practice Pointers

Why Cultivating Positive Company Culture Is Important

Building a cohesive team is essential for practice success.

Vance Thompson, MD, FACS

Health Care

Reforming America's Health Care System

A look at the Trump administration's approach.

David W. Parke II, MD


Virtual Field

Mark Harooni, MD


The Buzz on